mds/aml overlap and novel therapies with dr. naval daver
Published 6 years ago • 1.1K plays • Length 9:29Download video MP4
Download video MP3
Similar videos
-
42:24
understanding the overlap between mds and pnh
-
1:36
innovations in mds and aml treatment
-
1:31:23
mds classification & prognosis
-
1:09
dr. daver on the rationale of azacitidine and nivolumab in acute myeloid leukemia
-
4:32
assistant prof. naval daver | immunotherapies in aml / nivolumab with aza in pts with relapsed aml
-
22:47
one very annoying thing about heat pumps - time-temperature defrost
-
9:56
why do we...irradiate blood?
-
4:48
alan list: is luspatercept a new option for patients with mds?
-
1:13
expanding treatment options for aml to patients with mds
-
19:42
covid 19 focus on mds mpn overlap
-
2:16
current and future treatment approaches for hr-mds
-
1:20
distinguishing between aml and mds and addressing overlap between these diseases
-
1:09
differences and similarities between mds and aml & how this can inform treatment decisions
-
1:00:54
managing higher risk mdl and aml
-
4:18
phase i trial investigating cd8-depleted hla-mismatched unrelated dli in patients with mds and aml
-
2:17
meet leukemia oncologist naval daver, m.d.
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
2:18
antibody therapies for aml and mds
-
33:29
higher-risk mds and aml: how new guidelines are changing diagnosis, classification and management
-
1:34
are there different types of mds? #aml
-
4:21
ash 2017 update on progress with novel aml treatments at md anderson
-
1:55
what is supportive care for mds?